RINT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.876000E-01
Normal-vs-Stage2
4.272800E-01
Normal-vs-Stage3
4.037000E-01
Normal-vs-Stage4
7.404600E-01
Stage1-vs-Stage2
2.738800E-01
Stage1-vs-Stage3
1.868200E-01
Stage1-vs-Stage4
5.875800E-01
Stage2-vs-Stage3
2.829000E-01
Stage2-vs-Stage4
7.430200E-01
Stage3-vs-Stage4
3.386600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.104200E-01
Normal-vs-AfricanAmerican
9.452800E-01
Normal-vs-Asian
4.737200E-01
Caucasian-vs-AfricanAmerican
4.381000E-01
Caucasian-vs-Asian
6.709800E-01
AfricanAmerican-vs-Asian
3.865600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.539600E-01
Normal-vs-Female
5.819200E-01
Male-vs-Female
6.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.988600E-01
Normal-vs-Age(41-60Yrs)
8.478600E-01
Normal-vs-Age(61-80Yrs)
3.610400E-01
Normal-vs-Age(81-100Yrs)
4.087200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.828400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.072600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.049200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.955850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.467200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.740600E-01
Normal-vs-Daily Drinker
4.146000E-01
Normal-vs-Weekly Drinker
5.868000E-01
Normal-vs-Occasional Drinker
6.209000E-01
Normal-vs-Social Drinker
8.773400E-01
Non Drinker-vs-Daily Drinker
8.894000E-01
Non Drinker-vs-Weekly Drinker
6.434600E-01
Non Drinker-vs-Occasional Drinker
6.136800E-01
Non Drinker-vs-Social Drinker
9.758000E-02
Daily Drinker-vs-Weekly Drinker
5.441800E-01
Daily Drinker-vs-Occasional Drinker
5.246800E-01
Daily Drinker-vs-Social Drinker
8.423800E-02
Weekly Drinker-vs-Occasional Drinker
9.844000E-01
Weekly Drinker-vs-Social Drinker
2.585200E-01
Occasional Drinker-vs-Social Drinker
2.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.568000E-01
Normal-vs-Grade 2
5.297200E-01
Normal-vs-Grade 3
1.193760E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.298400E-01
Grade 1-vs-Grade 3
9.474400E-01
Grade 1-vs-Grade 4
2.568000E-01
Grade 2-vs-Grade 3
3.662600E-01
Grade 2-vs-Grade 4
5.297200E-01
Grade 3-vs-Grade 4
1.193760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.362000E-01
Normal-vs-NonDiabetic
5.475400E-01
Diabetic-vs-NonDiabetic
2.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.252600E-01
Normal-vs-NoPancreatitis
4.565400E-01
Pancreatitis-vs-NoPancreatitis
5.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.797000E-01
Normal-vs-N1
3.782000E-01
N0-vs-N1
3.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.052800E-01
Normal-vs-TP53-NonMutant
9.475200E-01
TP53-Mutant-vs-TP53-NonMutant
7.717800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
